CellmAbs

A Leap Forward in Oncology

Big Idea

CellmAbs,a spinoff from Lisbon NOVA University, offers an innovative immuno-oncology technology. It develops a new class of immunotherapies to treat solid tumours, particularly in the approach to pancreatic cancer, colorectal cancer, bladder cancer, stomach cancer, breast cancer and other cancers.

Year Invested

2019

Sector

Life Sciences

Stage

Seed

Team

Nuno Prego Ramos and Paula Videira.